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radioluminescence from Al2O3:C crystals (Landauer Inc., USA). 
This detector system comprised four probes, each of 1 mm 
diameter. Alanine pellets (4.8 mm diameter and 2.8 mm 
thickness) were used for integrated dose measurements. Due 
to the limited sensitivity of alanine, we scaled the treatment 
by a factor of 5 or more. Mid-plane measurements were 
carried out in a thorax phantom (002LFC, CIRS, USA) and 
surface measurements (with and without bolus covering) 
were carried out on an Alderson radiotherapy phantom 
(Radiology Support Devices, USA).  
Results: Measured midplane doses differed from the 
treatment planning system by less than 1.6% for the alanine 
pellets and 2.2 % for the fiber-coupled dosimetry. Larger 
deviations (up to 10%) were seen for the surface doses 
measured at head, thorax and hip positions. The standard 
uncertainty of the alanine and the fiber-coupled 
measurements was 1.6% and 5%, respectively. The large 
uncertainty in the fiber measurements was due to 
imperfections in the calibration procedure. The fiber system 
had a reproducibility of 0.3%. 
Conclusions: The study supports that the developed toolkit is 
useful for commissioning of new treatments. The alanine 
provided traceability for non-reference conditions and the 
fiber-coupled dosimetry provided fast, online measurements 
with minimal perturbation and in vivo measurement 
capability. The fiber system essentially had the same 
dosimetric characteristics as commercially available optically 
stimulating luminescence detectors (OSLDs). The advance of 
the fiber system was that results could be obtained online 
and with high time resolution. Thus, we obtained doses for 
each individual field in real time. Compared with organic 
scintillators, Al2O3:C crystals further provided improved 
reduction of the light generated in the fiber cable during 
irradiations.  
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Purpose/Objective: Limited clinical data with respect to 
peripheral doses is available, demonstrating differences 
between VMAT and IMRT. The aim of this work was to 
measure the low dose distribution in peripheral regions 
(thyroid, lung, stomach, gonads) for prostate, lung and 
rectum plans in a phantom and compare the results between 
IMRT and VMAT.  
Materials and Methods: In this study 28 plans were selected 
at Institut Jules Bordet : 11 prostate plans, 8 rectum plans 
and 9 lung plans originated from previously treated patients. 
The total doses delivered were 45-66 Gy, using different 
fractionation schemes for each pathology. They were both 
computed for VMAT and IMRT modalities. All the 
measurements were performed with an Elekta InfinityTM+ 
AgilityTMHead (6MV). Alderson Phantom provided the human 
like medium for the irradiation. For the group of prostate and 
rectum plans, we used 4 TLDs for each treatment plan. They 
were placed at specific points, close to sensitive organs, 
having a higher probability of radiation induced effects: 
thyroid, lung (thorax), stomach and gonads. For lung plans, 3 
TLDs were placed at the thyroid, stomach and gonads.  
Results: VMAT showed lower absorbed doses for peripheral 
organs farther from the isocenter field, while IMRT presented 
a decrease in absorbed doses in peripheral organs closer to 
the irradiation field. VMAT technique increases the scattering 
from the patient due to the full rotation gantry with beam 
on. Then the peripheral organs closer to the irradiation field 
have an increase in absorbed dose. IMRT treatment increases 
the leakage radiation from the machine, which contributes 
with dose at distance and then the increase of absorbed dose 
for organs farther from the irradiation field. 
Conclusions: To our knowledge this study is the most 
informative in terms of number of samples. The results show 
that the scattered dose is very important close to the in-field 
region. As the distance from isocenter increases, the leakage 
dose becomes predominant. This aspect is also relevant when 
using the cancer risk model. This is important for young 
patients or children, who are still in a very active cell 
proliferation phase of their lives and have time to develop 
other cancers in the future. Future works should be 
performed to evaluate the most common radio-induced 
cancers related for each pathology. That would allow 
physicists and physicians to decide which modality of 
treatment to choose with a decreased risk for young patients.  
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Purpose/Objective: Small field dosimetry constitutes a 
critical issue in modern radiotherapy. Various detectors had 
been designed to analyse fields up to 4x4 cm2: among these 
Exradin A26 Ion chamber (Standard Imaging), recently 
commercialized. The aim of this work is to characterize this 
ionization chamber (IC) for small field dosimetry. 
Materials and Methods: A26 IC (collecting volume 0.015 cc, 
typical of microchambers), was irradiated with a 6 MV photon 
beam provided by a Elekta Synergy Linac. All measurements 
were performed in water. The signal was collected by PC 
Electrometer (Sun Nuclear). Short term stability, dose 
linearity and dependence on dose rate had been tested for 
10x10 and 4x4 cm2 fields. The behaviour of Ppol and Pion 
correction factors had been examined varying the field sizes 
from 1x1 cm2 to 10x10 cm2. Output factors (OF) were 
acquired for fields ranging between 1x1 cm2 and 25x25 cm2. 
Field profiles and Percentage Depth Dose (PDD) 
measurements were performed for 1x1, 2x2 and 3x3 cm2 
fields. OF comparison had been executed with a diode 
detector (EDGE diode, Sun Nuclear); profiles and PDD were 
compared with measurements obtained by A1SL IC (Standard 
Imaging, collecting volume 0.053 cc) and diode. 
Results: A26 short term measurements showed good stability 
(standard deviations lower than 0.2%) for both 10x10 and 4x4 
cm2 fields. Dose linearity had been verified (r2 ≈ 1); dose rate 
readings from 37 to 700 MU/min showed a 3% and 4% 
maximum variation for 10x10 and 4x4 cm2 fields respectively, 
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at low dose rates. Ppol maximum variation, for fields up to 
10x10 cm2, was 0.8% while Pion showed a 0.4% maximum 
difference for the examined fields. The comparison between 
OF acquired with A26 and diode showed a mean difference of 
0.7%; an exception is given by 1x1 cm2 field, in which a 7.7% 
discrepancy between detectors was noticed. Profiles scanned 
by A26 were in agreement with diode (0.5 mm maximum 
penumbra variation for 2x2 cm2 field). The comparison with 
profiles acquired by A1SL showed a 0.2 mm maximum 
penumbra difference for 3x3 cm2 field. A26 Full Width at Half 
Maximum (FWHM) measurements showed a 0.4 mm (for 3x3 
cm2 field) and 0.2 mm (for 1x1 and 2x2 cm2 fields) maximum 
difference compared to the results obtained by diode and 
A1SL respectively. As regards PDD, a good agreement was 
achieved between A26 and both diode and A1SL readings for 
2x2 and 3x3 cm2 fields (maximum difference 1.7%); for 1x1 
cm2 field (as shown in figure), as depth increased, a not 
negligible difference (up to 10%) was observed between A26 
and A1SL while the comparison with diode confirmed the 
good accordance shown previously. 
 
 
 
Conclusions: Not negligible differences between detectors 
were observed. Montecarlo correction factors for diode might 
explain the OF discrepancy with A26, while the A1SL bigger 
collecting volume could justify the variation observed in 1x1 
cm2 field PDD. Due to the lack of a gold standard detector for 
small field dosimetry, the previous measurements showed the 
reliability of A26 as detector for small fields. 
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Purpose/Objective: Contemporary radiotherapy approaches 
widely employ ‘non standard’ photon beams raising 
unprecedented challenges for absolute dose determination. 
In particular, standard reference dosimetry for small fields 
used in stereotactic radiosurgery treatments is substantially 
unfeasible. The implementation of new technologies for 
dosimetry is mandatory. The aim of this work is to 
characterize Exradin W1, a plastic scintillation detector 
manufactured by Standard Imaging, Inc. that seems to be 
promising in term of water equivalence, spatial resolution, 
dose rate and energy dependence for small field dosimetry 
purpose. 
Materials and Methods: Exradin W1 was irradiated in vertical 
position (axis parallel to beam axis) in a water phantom with 
6MV and 10 MV photon beams produced by a Varian 
Accelerator. Beam stability during irradiation was monitored 
with a PTW Semiflex Ionization Chamber (IC). W1 dose 
calibration for both energies was carried on at 10 cm depth 
in a 10x10cm2 field, in two different condition of irradiated 
optical fiber length. Dose linearity was investigated at a dose 
rate of 300MU/min ranging from 4 to 1000 MU in 10x10 cm2 
field. Dose-rate dependence was also studied varying from 
100 to 600 MU/min. The detector response depending on 
gantry orientation was tested in a 5x5cm2 field, at 10° step 
angles from 340°to 40°. Relative output factors (ROF) were 
measured at 10cm depth for both energies with W1, PTW 
PinPoint IC and PTW microdiamond detector up to 0.4x.04cm2 
field. Results were also compared with Pinnacle3 and 
RayStation TPSs calculated values. 
Results: Detector dose response showed a optimal linearity 
both for 6MV and 10MV, less than 0.5% up to 4MU and 1% for 
MU<4 but due to accelerator behavior. Regarding dose-rate 
dependence a standard deviation of 0.3% was observed 
among measurements performed in the range all dose-rates 
tested. Detector response showed a not negligible 
dependence on the length of fiber irradiated, observed both 
in calibration setup and during measurements at different 
gantry angle.  Output factor measured with the 3 detectors 
showed a maximum difference of 1% for the 1x1cm2 field. A 
poorer agreement was found for smaller field dimension. As 
expected, the same trend was observed comparing W1 
detector measured ROF with calculated values, that is, a 
difference less than 0.5% up to 1x1cm2 and worse beyond. 
Conclusions: Exradin W1 is a new detector that seems to 
introduce a minimum perturbation of the beam fluence. It is 
fast in data collection and easy to set up and manage. It 
show a good behavior in term of dose linearity and dose rate 
independence.  
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Purpose/Objective: Methyl Viologen (MV) is a chemical 
dosimeter historically used in pulsed radiolysis studies since 
it gives a sub-microsecond response to the delivered dose. 
MV is also reported to be dose-rate independent up to ultra-
high (≥ 106 Gy/s) dose-rates. The recent interest into using 
MV as a clinical dosimeter in radiotherapy is coupled with 
promising new radiotherapy techniques operating at these 
dose-rates, e.g. Flash irradiation and synchrotron radiation 
therapy. The purpose of this study is to characterize MV as a 
clinical dosimeter and to reveal its potential use in routine 
measurements at a radiotherapy department. 
Materials and Methods: When ionizing radiation interacts 
with a MV solution it produces radicals, which display a 
characteristic blue color. This occurs as visible light is 
strongly absorbed, with absorbance peaks at wavelengths (λ) 
of around 395 nm and 603 nm. Consequently, the absorbed 
dose by a MV solution is readily determined by measuring the 
optical density (absorbance) at those particular wavelengths 
